By Pooja Toshniwal PahariaJan 23 2023Reviewed by Aimee Molineux In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests , and the development of next-generation LFTs based on lessons learnt from the severe acute respiratory syndrome coronavirus 2 pandemic.
The changing landscape of LFT diagnostics LFTs were initially used as radiological immunoassays and latex agglutination tests and enabled paper-based dipstick tests for urinary glucose quantification. Eventually, the tests were used for pregnancy-related, serological assessments and diagnosis of human immunodeficiency virus infections.
Pre-COVID-19 pandemic LFTs used HIV antibodies and targeted antigens and antibodies. The tests were used for self-testing, clinical diagnosis, and screening at homes, clinics, and community-based settings, using gold nanoparticles and latex beads, with manually captured results. During COVID-19, LFTs used SARS-CoV-2 antigens, and their use was expanded to surveillance efforts.
Multiplexing and using quantum- and nano-materials, nucleic-acid-based LFTs, machine learning, and CRISPR could improve LFT connectivity and accuracy.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NewsMedical - 🏆 19. / 71 Read more »
Source: NewsMedical - 🏆 19. / 71 Read more »
Source: BBCNews - 🏆 3. / 97 Read more »
Source: nottslive - 🏆 96. / 52 Read more »
Source: bikerumor - 🏆 65. / 61 Read more »
Source: MENnewsdesk - 🏆 23. / 69 Read more »